---
layout: post
title: "Chemistry, Manufacturing, and Control Information for Human Gene Therapy Investigational New Drug Applications; Guidance for Industry; Availability"
date: 2026-02-05 19:08:19 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2020-01701
original_published: 2020-01-30 00:00:00 +0000
significance: 8.00
---

# Chemistry, Manufacturing, and Control Information for Human Gene Therapy Investigational New Drug Applications; Guidance for Industry; Availability

**Published:** February 05, 2026 19:08 UTC
**Source:** Federal Register
**Original Published:** January 30, 2020 00:00 UTC
**Document Number:** 2020-01701

## Summary

The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance entitled "Chemistry, Manufacturing, and Control (CMC) Information for Human Gene Therapy Investigational New Drug Applications (INDs); Guidance for Industry." The guidance document provides sponsors of human gene therapy INDs with recommendations regarding CMC information to be submitted in an IND. The guidance document informs sponsors how to provide sufficient CMC information required to assure product safety, identity, quality, purity, and strength (including potency) of the investigational product. The guidance applies to human gene therapy products and to combination products that contain a human gene therapy in combination with a drug or device. The guidance announced in this notice finalizes the draft guidance of the same title dated July 2018 and supersedes the document entitled "Guidance for FDA Reviewers and Sponsors: Content and Review of Chemistry, Manufacturing, and Control (CMC) Information for Human Gene Therapy Investigational New Drug Applications (INDs)," dated April 2008 (April 2008 guidance).

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2020/01/30/2020-01701/chemistry-manufacturing-and-control-information-for-human-gene-therapy-investigational-new-drug)
- API: https://www.federalregister.gov/api/v1/documents/2020-01701

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
